Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells ; volume:7 ; number:1 ; day:30 ; month:6 ; year:2008 ; pages:1-10 ; date:12.2008
Molecular cancer ; 7, Heft 1 (30.6.2008), 1-10, 12.2008
- Urheber
-
Fandy, Tamer E.
Shankar, Sharmila
Srivastava, Rakesh K.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-7-60
- URN
-
urn:nbn:de:101:1-2021080822305447807047
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fandy, Tamer E.
- Shankar, Sharmila
- Srivastava, Rakesh K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Role of Smac/DIABLO in cancer progression
Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein
Mechanismen der Apoptoseinduktion durch das proapoptotische Protein Smac/DIABLO
Mechanismen der Apoptoseinduktion durch das proapoptotische Protein Smac/DIABLO
A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB
Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
High Smac/DIABLO expression is associated with early local recurrence of cervical cancer
UHRF1 depletion sensitizes retinoblastoma cells to chemotherapeutic drugs via downregulation of XRCC4
Smac/DIABLO protein acts as an independent prognostic factor in oral squamous cell carcinoma
Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis
Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma
Role of Smac/DIABLO in cancer progression
Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein
Mechanismen der Apoptoseinduktion durch das proapoptotische Protein Smac/DIABLO
Mechanismen der Apoptoseinduktion durch das proapoptotische Protein Smac/DIABLO
A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB
Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
High Smac/DIABLO expression is associated with early local recurrence of cervical cancer
UHRF1 depletion sensitizes retinoblastoma cells to chemotherapeutic drugs via downregulation of XRCC4
Smac/DIABLO protein acts as an independent prognostic factor in oral squamous cell carcinoma
Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis
Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma
Role of Smac/DIABLO in cancer progression
Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein
Mechanismen der Apoptoseinduktion durch das proapoptotische Protein Smac/DIABLO
Mechanismen der Apoptoseinduktion durch das proapoptotische Protein Smac/DIABLO
A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB
Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
High Smac/DIABLO expression is associated with early local recurrence of cervical cancer
UHRF1 depletion sensitizes retinoblastoma cells to chemotherapeutic drugs via downregulation of XRCC4
Smac/DIABLO protein acts as an independent prognostic factor in oral squamous cell carcinoma
Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis